Tower Research Capital LLC (TRC)
Position in LIPO — Lipella Pharmaceuticals Inc.
CIK 1533421
NEW YORK, NY
Position in LIPO
as of Mar 31, 2025
· filed May 15, 2025
Position Value
$6,797
+$3,166 QoQ
Shares Held
2,708
+181.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LIPO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,731,131 across 466 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in LIPO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-03-31 | $6,797 | 2,708 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,631 | 7,694 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,473 | 7,718 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,279 | 7,708 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,057 | 6,919 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,380 | 4,920 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,436 | 1,606 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,325 | 2,218 | Shares | Defined | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||